🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Single cell biomass tracking allows identification and isolation of rare targeted therapy-resistant DLBCL cells within a mixed population

The Analyst(2021)10.1039/d0an01769hSource: DataRank Database

Single cell biomass tracking allows identification and isolation of rare targeted therapy-resistant DLBCL cells within a mixed population is a research paper published in The Analyst (2021). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: hybridTopics (9)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Daniel Guest,Andrey Mikheykin,Amir A. Toor ORCID,Jason Reed ORCID,Graeme Murray ORCID

Live enrichment

PubMed:19767382

National Institutes of Health

Grant: R01CA185189

National Cancer Institute

Grant: P30CA016059

National Institutes of Health

Grant: 4P30CA016059-35

Massey Cancer Center Support Grant

National Institutes of Health

Grant: 1R01CA185189-01

(PQD5) Mass Profiling Melanoma Responses to Improve Therapy Choices and Prognosis

hybridLicense: cc-by-nc

publisherhttps://pubs.rsc.org/en/content/articlepdf/2021/an/d0an01769h

publisherhttp://pubs.rsc.org/en/content/articlepdf/2021/AN/D0AN01769H

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8323818

https://doi.org/10.1039/d0an01769h

https://pubmed.ncbi.nlm.nih.gov/33426547

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

ChemistryPhosphatidylinositol 3-KinasesHumansBiomassLymphoma, Large B-Cell, DiffuseProtein Kinase Inhibitors

Sustainable Development Goals

SDG 3: 3. Good health